Automated nano-electrospray mass spectrometry for protein-ligand screening by noncovalent interaction applied to human H-FABP and A-FABP
(2003) In Journal of Biomolecular Screening 8(3). p.247-256- Abstract
- A method for ligand screening by automated nano-electrospray ionization mass spectrometry (nano-ESI/MS) is described. The core of the system consisted of a chip-based platform for automated sample delivery from a 96-well plate and subsequent analysis based on noncovalent interactions. Human fatty acid binding protein, H-FABP (heart) and A-FABP (adipose), with small potential ligands was analyzed. The technique has been compared with a previously reported method based on nuclear magnetic resonance (NMR), and excellent coorelation with the found hits was obtained. In the current MS screening method, the cycle time per sample was 1.1 min, which is approximately 50 times faster than NMR for single compounds and approximately 5 times faster for... (More)
- A method for ligand screening by automated nano-electrospray ionization mass spectrometry (nano-ESI/MS) is described. The core of the system consisted of a chip-based platform for automated sample delivery from a 96-well plate and subsequent analysis based on noncovalent interactions. Human fatty acid binding protein, H-FABP (heart) and A-FABP (adipose), with small potential ligands was analyzed. The technique has been compared with a previously reported method based on nuclear magnetic resonance (NMR), and excellent coorelation with the found hits was obtained. In the current MS screening method, the cycle time per sample was 1.1 min, which is approximately 50 times faster than NMR for single compounds and approximately 5 times faster for compound mixtures. High reproducibility was achieved, and the protein consumption was in the range of 88 to 100 picomoles per sample. Futhermore, a novel protocol for preparation of A-FABP without the natural ligand is presented. The described screening approach is suitable for ligand screening very early in the drug discovery process before conventional high-throughput screens (HTS) are developed and/or used as a secondary screening for ligands identified by HTS. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/128015
- author
- Benkestock, K ; van Pelt, C K ; Åkerud, Tomas LU ; Sterling, A ; Edlund, P-O and Roeraade, J
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- in
- Journal of Biomolecular Screening
- volume
- 8
- issue
- 3
- pages
- 247 - 256
- publisher
- SAGE Publications
- external identifiers
-
- pmid:12857378
- wos:000183364000002
- scopus:0038550485
- ISSN
- 1087-0571
- DOI
- 10.1177/1087057103008003002
- language
- English
- LU publication?
- yes
- id
- 7e365256-489b-47c5-bd3c-9a327b1d526e (old id 128015)
- date added to LUP
- 2016-04-01 11:36:42
- date last changed
- 2025-04-03 18:08:17
@article{7e365256-489b-47c5-bd3c-9a327b1d526e, abstract = {{A method for ligand screening by automated nano-electrospray ionization mass spectrometry (nano-ESI/MS) is described. The core of the system consisted of a chip-based platform for automated sample delivery from a 96-well plate and subsequent analysis based on noncovalent interactions. Human fatty acid binding protein, H-FABP (heart) and A-FABP (adipose), with small potential ligands was analyzed. The technique has been compared with a previously reported method based on nuclear magnetic resonance (NMR), and excellent coorelation with the found hits was obtained. In the current MS screening method, the cycle time per sample was 1.1 min, which is approximately 50 times faster than NMR for single compounds and approximately 5 times faster for compound mixtures. High reproducibility was achieved, and the protein consumption was in the range of 88 to 100 picomoles per sample. Futhermore, a novel protocol for preparation of A-FABP without the natural ligand is presented. The described screening approach is suitable for ligand screening very early in the drug discovery process before conventional high-throughput screens (HTS) are developed and/or used as a secondary screening for ligands identified by HTS.}}, author = {{Benkestock, K and van Pelt, C K and Åkerud, Tomas and Sterling, A and Edlund, P-O and Roeraade, J}}, issn = {{1087-0571}}, language = {{eng}}, number = {{3}}, pages = {{247--256}}, publisher = {{SAGE Publications}}, series = {{Journal of Biomolecular Screening}}, title = {{Automated nano-electrospray mass spectrometry for protein-ligand screening by noncovalent interaction applied to human H-FABP and A-FABP}}, url = {{http://dx.doi.org/10.1177/1087057103008003002}}, doi = {{10.1177/1087057103008003002}}, volume = {{8}}, year = {{2003}}, }